Desmond Tutu Health Foundation
Cape Town, South Africa
4 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 4
Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
HIV Prevention
University of Witwatersrand, South Africa100 enrolled3 locationsNCT06485154
Recruiting
Phase 2
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Drug Susceptible Pulmonary Tuberculosis
Gates Medical Research Institute150 enrolled13 locationsNCT07525427
Recruiting
Phase 1Phase 2
AGILE (Early Phase Platform Trial for COVID-19)
COVID19
University of Liverpool600 enrolled7 locationsNCT04746183
Recruiting
Phase 4
Doravirine Dose Optimisation in Pregnancy
HIV
University of Liverpool76 enrolled1 locationNCT05630638
Recruiting
Phase 3
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
HIV Disease Progression
Population Health Research Institute8,000 enrolled52 locationsNCT05580666
Recruiting
Not Applicable
Assessing the Feasibility of Coach Mpilo for Men With TB and HIV
TuberculosisHIV
Arizona State University240 enrolled1 locationNCT07117370
Recruiting
Vaginal Microbiome Research Consortium for Africa
Healthy
University of Cape Town200 enrolled2 locationsNCT06662747
Recruiting
PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.
HIV InfectionSexual and Reproductive Health
Desmond Tutu HIV Foundation1,800 enrolled1 locationNCT06807736